Twist Bioscience Files Prospectus to Register Resale of Invenra Shares

What Happened
Twist Bioscience Corporation (TWST) filed a Current Report on Form 8-K on August 19, 2026 to disclose that it has filed a prospectus supplement to register the resale of shares issuable to Invenra Inc. This action is being taken pursuant to a Registration Rights Agreement dated February 11, 2026 and the related Stock Purchase Agreement dated February 11, 2026 between Twist and Invenra. The company also furnished a legal opinion from Orrick, Herrington & Sutcliffe LLP as Exhibit 5.1 in connection with the registration.

Key Details

• Filing date of this 8-K: August 19, 2026.
• Agreements involved: Registration Rights Agreement and Stock Purchase Agreement, each dated February 11, 2026.
• Purpose: prospectus supplement to register resale of shares issuable to Invenra.
• Exhibit filed: Opinion of Orrick, Herrington & Sutcliffe LLP (Exhibit 5.1).

Why It Matters
The prospectus supplement and registration filing are administrative steps to enable the resale of shares that Invenra may receive under the previously announced purchase agreement. For investors, this clarifies that Twist has taken the regulatory steps required to allow Invenra to resell shares under those agreements and provides the legal opinion supporting the registration filing.